Human endomyocardial biopsy specimen-derived stromal cells modulate angiotensin II-induced cardiac remodeling

Stem Cells Translational Medicine

Volumn 5, Issue 12, 2016, Pages 1707-1718

  Miteva, Kapka ^a   Van Linthout, Sophie ^a,b   Pappritz, Kathleen ^a   Müller, Irene ^a   Spillmann, Frank ^a   Haag, Marion ^a   Stachelscheid, Harald ^a   Ringe, Jochen ^a   Sittinger, Michael ^a   Tschöpe, Carsten ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Angiotensin II; Cardiac biopsy; Cardiomyocyte hypertrophy; Fibrosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; COLLAGEN TYPE 1; COLLAGEN TYPE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN; COLLAGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MALE; MIDDLE AGED; MOUSE; NONHUMAN; OXIDATIVE STRESS; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; STROMA CELL; WESTERN BLOTTING; ANIMAL; BIOPSY; C57BL MOUSE; CARDIAC MUSCLE; CARDIOMEGALY; CELL TRANSDIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; FIBROSIS; METABOLISM; MYOFIBROBLAST; PATHOLOGY; VASCULAR REMODELING;

ADULT; ANGIOTENSIN II; ANIMALS; BIOPSY; CARDIOMEGALY; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; COLLAGEN; FEMALE; FIBROBLASTS; FIBROSIS; HUMANS; IMMUNOMODULATION; MALE; MICE, INBRED C57BL; MYOCARDIUM; MYOFIBROBLASTS; OXIDATIVE STRESS; STROMAL CELLS; VASCULAR REMODELING; VENTRICULAR FUNCTION, LEFT;

EID: 84995939764     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2016-0031     Document Type: Article

References (55)

1. Wilson MS, Elnekave E, Mentink-Kane MM et al. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest 2007;117:2941–2951.
2. Olson ER, Naugle JE, Zhang X et al. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am J Physiol Heart Circ Physiol 2005;288: H1131–H1138.
3. Kvakan H, Kleinewietfeld M, Qadri F et al. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 2009;119:2904– 2912.
4. Hingtgen SD, Tian X, Yang J et al. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics 2006; 26:180–191.
5. Nakamura Y, Yoshiyama M, Omura T et al. Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovasc Res 2003;57:48–54.
6. Kim S, Yoshiyama M, Izumi Y et al. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 2001;103:148–154.
7. Pfeffer MA, Swedberg K, Granger CB et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme. Lancet 2003;362: 759–766.
8. Van Linthout S, Savvatis K, Miteva K et al. Mesenchymal stem cells improve murine acute Coxsackievirus B3-induced myocarditis. Eur Heart J 2011;32:2168–2178.
9. Sorrell JM, Baber MA, Caplan AI. Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A 2009;15: 1751–1761.
10. Haag M, Van Linthout S, Schröder SE et al. Endomyocardial biopsyderived adherent proliferating cells - a potential cell source for cardiac tissue engineering. J Cell Biochem 2010;109: 564–575.
11. Choi YH, Saric T, Nasseri B et al. Cardiac cell therapies: The next generation. Cardiovasc Ther 2011;29:2–16.
12. Miteva K, Haag M, Peng J et al. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis. PLoS One 2011;6:e28513.
13. Haag M, Stolk M, Ringe J et al. Immune attributes of cardiac-derived adherent proliferating (CAP) cells in cardiac therapy. J Tissue Eng Regen Med 2013;7:362–370.
14. Tschöpe C, Kherad B, Schultheiss HP. How to perform an endomyocardial biopsy? Turk Kardiyol Dern Ars 2015;43:572–575.
15. Tschöpe C, Bock CT, Kasner M et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 2005;111: 879–886.
16. Westermann D, Becher PM, Lindner D et al. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo. Basic Res Cardiol 2012;107:308.
17. McBride C, Gaupp D, Phinney DG. Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR. Cytotherapy 2003;5:7–18.
18. Van Linthout S, Lusky M, Collen D et al. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector. Gene Ther 2002;9: 1520–1528.
19. De Geest BR, Van Linthout SA, Collen D. Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells. Blood 2003;101: 2551–2556.
20. Savvatis K, van Linthout S, Miteva K et al. Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis. PLoS One 2012;7:e41047.
21. Spillmann F, Miteva K, Pieske B et al. High-density lipoproteins reduce endothelial-to-mesenchymal transition. Arterioscler Thromb Vasc Biol 2015;35:1774–1777.
22. Staal EM, Baan J, Jukema JW et al. Assessment of parallel conductance for the trans-cardiac conductance method: Can we use the hypertonic saline method with pulmonary artery injections? Physiol Meas 2004;25:565–576.
23. Shen WL, Gao PJ, Che ZQ et al. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem Biophys Res Commun 2006;339:337–343.
24. ELLS 2009;27:2734–2743.
25. Van Linthout S, Spillmann F, Lorenz M et al. Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor. Hypertension 2009;53:682–687.
26. Aragno M, Mastrocola R, Alloatti G et al. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 2008; 149:380–388.
27. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: New roles in inflammation, immunology and aging. EMBO Mol Med 2010;2: 247–257.
28. Noble A, Giorgini A, Leggat JA. Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage. Blood 2006;107:4475–4483.
29. Van Linthout S, Miteva K, Tschöpe C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res 2014;102:258–269.
30. Kurisu S, Ozono R, Oshima T et al. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 2003;41:99–107.
31. O’Riordan E, Mendelev N, Patschan S et al. Chronic NOS inhibition actuates endothelial-mesenchymal transformation. AmJ Physiol Heart Circ Physiol 2007;292:H285–H294.
32. Lan L, Chen Y, Sun C et al. Transplantation of bone marrow-derived hepatocyte stem cells transduced with adenovirus-mediated IL-10 gene reverses liver fibrosis in rats. Transpl Int 2008;21:581–592.
33. Mu W, Ouyang X, Agarwal A et al. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005;16:3651–3660.
34. Krishnamurthy P, Rajasingh J, Lambers E et al. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res 2009;104:e9–e18.
35. Li Z, Wei H, Deng L et al. Expression and secretion of interleukin-1b, tumour necrosis factor-a and interleukin-10 by hypoxia- and serum-deprivation-stimulated mesenchymal stem cells. FEBS J 2010;277:3688–3698.
36. Occleston NL, O’Kane S, GoldspinkNet al. New therapeutics for the prevention and reduction of scarring. Drug Discov Today 2008;13: 973–981.
37. Yamamoto T, Eckes B, Krieg T. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: Differential regulation by transforming growth factor-beta and monocyte che-moattractant protein-1. Biochem Biophys Res Commun 2001;281:200–205.
38. Jin Y, Liu R, Xie J et al. Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Lab Invest 2013;93:801–811.
39. Siwik DA, Pagano PJ, Colucci WS. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 2001;280: C53–C60.
40. Swaney JS, Roth DM, Olson ER et al. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overex-pression of adenylyl cyclase. Proc Natl Acad Sci USA 2005;102:437–442.
41. Cheng TH, Shih NL, Chen SY et al. Nitric oxide inhibits endothelin-1-induced cardiomyocyte hypertrophy through cGMP-mediated suppression of extracellular-signal regulated kinase phosphorylation. Mol Pharmacol 2005;68: 1183–1192.
42. Gunnett CA, Heistad DD, Berg DJ et al. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol 2000;279: H1555–H1562.
43. Kaur K, Sharma AK, Dhingra S et al. Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 2006;41:1023–1030.
44. Olson ER, Shamhart PE, Naugle JE et al. Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension 2008;51:704–711.
45. Molkentin JD. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 2004;63:467–475.
46. Calderone A, Thaik CM, Takahashi N et al. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 1998;101:812–818.
47. Ichinose F, Bloch KD, Wu JC et al. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 2004;286:H1070–H1075.
48. Ruetten H, Dimmeler S, Gehring D et al. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovasc Res 2005;66:444–453.
49. Buys ES, Raher MJ, Blake SL et al. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload. Am J Physiol Heart Circ Physiol 2007;293: H620–H627.
50. Barouch LA, Harrison RW, Skaf MW et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002;416:337–339.
51. Nonaka-Sarukawa M, Okada T, Ito T et al. Adeno-associated virus vector-mediated systemic interleukin-10 expression ameliorates hypertensive organ damage in Dahl salt-sensitive rats. J Gene Med 2008;10:368– 374.
52. Hovsepian E, Penas F, Siffo S et al. IL-10 inhibits the NF-kB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes. PLoS One 2013;8: e79445.
53. Westermann D, Lindner D, Kasner M et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 2011;4:44–52.
54. Masiha S, Sundström J, Lind L. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J Hum Hypertens 2013;27:13–17.
55. Burchfield JS, Iwasaki M, Koyanagi M et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 2008;103:203–211.